within Pharmacolibrary.Drugs.ATC.R;

model R02AA06
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 0.0,
    adminDuration  = 600,
    adminMass      = 2.5 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.001,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>R02AA06</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Cetylpyridinium is a quaternary ammonium compound used as an antiseptic and disinfectant. It is primarily indicated as an active ingredient in mouthwashes, throat lozenges, and other oral hygiene products for its activity against bacteria and some viruses. Cetylpyridinium is not systemically absorbed in significant amounts and is generally considered safe for topical use in approved oral care products.</p><h4>Pharmacokinetics</h4><p>No published data available for systemic pharmacokinetic parameters, as cetylpyridinium is not intended for systemic therapy and is primarily used topically in the oral cavity. No reported values in healthy humans, patients, or special populations.</p><h4>References</h4><ol><li><p>Darsazan, B, et al., &amp; Mortazavi, SA (2018). Evaluation of Ion-pair Formation of Adefovir to Improve Permeation across Artificial and Biological Membranes. <i>Journal of pharmacy &amp; pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques</i> 21(1) 160–170. DOI:<a href=\"https://doi.org/10.18433/jpps29394\">10.18433/jpps29394</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/29789103/\">https://pubmed.ncbi.nlm.nih.gov/29789103</a></p></li><li><p>Matsuo, K, et al., &amp; Van Meerbeek, B (2019). Rechargeable anti-microbial adhesive formulation containing cetylpyridinium chloride montmorillonite. <i>Acta biomaterialia</i> 100 388–397. DOI:<a href=\"https://doi.org/10.1016/j.actbio.2019.09.045\">10.1016/j.actbio.2019.09.045</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/31568874/\">https://pubmed.ncbi.nlm.nih.gov/31568874</a></p></li><li><p>García-Godoy, F (2005). Advances in therapeutic mouthrinses. <i>American journal of dentistry</i> 18 Spec No 2A–None. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/16178128/\">https://pubmed.ncbi.nlm.nih.gov/16178128</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end R02AA06;
